The Fund's aim is to achieve long-term capital growth from a UK equity portfolio comprising our 'best ideas' within the UK market.
Name | % Net Assets |
---|---|
Healthcare Locums | 5.7% |
Pace | 5.4% |
Afren | 5.1% |
Firstgroup | 4.1% |
Melrose | 3.6% |
International Power | 3.5% |
C&C Group (Irish) | 3.5% |
Valiant Petroleum | 3.4% |
Innovation Group | 3.2% |
Norseman Gold Resources | 3.1% |
Key | % Net Assets |
---|---|
Healthcare Locums | 5.7% |
Pace | 5.4% |
Afren | 5.1% |
Firstgroup | 4.1% |
Other | 79.7% |
Date | 21-Nov-2024 |
---|---|
NAV | 689.90p |
Currency | GBP |
Change | -0.80p |
% | -0.12% |
YTD change | 27.70p |
YTD % | 4.18% |
Fund Inception | 20/03/2000 |
---|---|
Fund Manager | Neil Veitch / Margaret Lawson |
TER | 1.10 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £250000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 1.00% |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.18 |
You are here: research